SCHEMBL146698

SCHEMBL146698

Cc1ccc[nH]c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL9277907 0.89 MAPT (0.44)
SCHEMBL9702809 0.87 DAO (0.47)
SCHEMBL19496948 0.83 MAPK14 (0.38)
Phenylhydrazine SCHEMBL9701687 0.81 IDO1 (0.48)
SCHEMBL28563542 0.80 NPC1 (0.47)
Malic Acid SCHEMBL5987160 0.76 SMN1; SMN2 (0.46)
SCHEMBL31104795 0.75
SCHEMBL2101505 0.72 AURKA (0.56)
SCHEMBL30664795 0.72 AURKA (0.45)
SCHEMBL1422273 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1084 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042772-A1 FURO PYRIMIDINE DERIVATES MERCK PATENT GMBH (DE) 2026-02-12 US claimed
US-12352695-B2 System and method for monitoring the health of dialysis patients VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2025-07-08 US claimed
US-20250002475-A1 PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS EPICS THERAPEUTICS (BE) 2025-01-02 US claimed
EP-4433485-A1 ADENOSINE RECEPTOR ANTAGONISTS Crossignal Therapeutics, Inc. (US) 2024-09-25 EP claimed
US-12091400-B2 Piperidine derivatives as METTL3 inhibitors EPICS THERAPEUTICS (BE) 2024-09-17 US claimed
US-20240270716-A1 PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS EPICS THERAPEUTICS (BE) 2024-08-15 US claimed
EP-4396191-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2024-07-10 EP claimed
CN-117379546-A Novel near infrared two-region excited multi-mode diagnosis and treatment nanoparticle as well as preparation method and application thereof 深圳大学 2024-01-12 CN claimed
WO-2023033740-A9 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2023-12-28 WO claimed
US-20230243752-A1 SYSTEM AND METHOD FOR MONITORING THE HEALTH OF DIALYSIS PATIENTS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2023-08-03 US claimed
EP-1999340-A1 METHOD OF FRACTURING A COALBED GAS RESERVOIR Sclumberger Technology B.V. (NL) 2008-12-10 EP claimed
WO-2008094834-A2 MULTI-FUNCTIONAL DRUG CARRIERS NITTO DENKO CORPORATION (JP) 2008-08-07 WO claimed
WO-2007120923-A1 SUBSTANTIALLY PURE O-DESMETHYLVENLAFAXINE AND PROCESSES FOR PREPARING IT TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2007-10-25 WO claimed
WO-2007110562-A1 METHOD OF FRACTURING A COALBED GAS RESERVOIR SCHLUMBERGER TECHNOLOGY B.V. (NL) 2007-10-04 WO claimed
US-7150856-B2 On-spot selectively activated hydrophobic slide and preparation thereof INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2006-12-19 US claimed
US-7118908-B2 On-spot selectively activated hydrophobic slide and preparation thereof Jan, Bor-Iuan (TW) 2006-10-10 US claimed
US-7105340-B2 On-spot selectively activated hydrophobic slide and preparation thereof Jan, Bor-Iuan (TW) 2006-09-12 US claimed
US-20050222446-A1 Process for the production of hydrocarbyl silyl carboxylate compounds SIGMA COATINGS B.V. (NL) 2005-10-06 US claimed
EP-1572702-A1 PROCESS FOR THE PRODUCTION OF SILYL CARBOXYLATE MONOMERS SIGMA COATINGS B.V. (NL) 2005-09-14 EP claimed
WO-2004056838-A1 PROCESS FOR THE PRODUCTION OF SILYL CARBOXYLATE MONOMERS SIGMA COATINGS B.V. (NL) 2004-07-08 WO claimed